Molina Healthcare (NYSE:MOH) Issues FY 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 24.500- for the period, compared to the consensus EPS estimate of 26.070. The company issued revenue guidance of -.

Molina Healthcare Price Performance

Shares of MOH traded up $2.07 during mid-day trading on Friday, hitting $287.08. The company’s stock had a trading volume of 378,081 shares, compared to its average volume of 606,493. The firm has a 50-day simple moving average of $298.78 and a 200 day simple moving average of $318.38. The firm has a market capitalization of $16.42 billion, a P/E ratio of 14.58, a P/E/G ratio of 0.96 and a beta of 0.54. Molina Healthcare has a 1-year low of $272.69 and a 1-year high of $423.92. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 27.88% and a net margin of 2.92%. Analysts predict that Molina Healthcare will post 23.44 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on MOH. Robert W. Baird cut their price target on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a report on Friday. Truist Financial cut their price target on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays boosted their price target on Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a report on Friday, October 25th. Finally, Wells Fargo & Company boosted their price target on Molina Healthcare from $360.00 to $362.00 and gave the stock an “equal weight” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $358.42.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.